Sonoma Pharmaceuticals Inc (SNOA) — Cash Flow Reinvestment Rate

Latest as of March 2025: 0.09x

Sonoma Pharmaceuticals Inc (SNOA) has a Cash Flow Reinvestment Rate of 0.09x as of March 2025, reinvesting $49.00K (capex $2.00K plus investments $-47.00K) from operating cash flow of $565.00K. Explore Sonoma Pharmaceuticals Inc (SNOA) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.09x
(Capex + Investments) / Operating CF

Total Reinvested

$49.00K
Capex + Investments

Operating Cash Flow

$565.00K
USD

Capital Expenditures

$2.00K
USD

Sonoma Pharmaceuticals Inc Cash Flow Reinvestment Rate (2013–2013)

Historical reinvestment intensity for Sonoma Pharmaceuticals Inc across 1 annual periods. Also explore SNOA asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Sonoma Pharmaceuticals Inc (2013–2013)

Year-by-year capital reinvestment analysis for Sonoma Pharmaceuticals Inc. For live market cap and broader valuation context, see Sonoma Pharmaceuticals Inc (SNOA) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2013 0.22x $257.00K $1.15 Million $257.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow